These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7729303)

  • 21. Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients.
    Durlach V; Gillery P; Bertin E; Taupin JM; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1996 Oct; 22(5):319-23. PubMed ID: 8896993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein levels in non-insulin-dependent diabetes mellitus with clinical macroangiopathy.
    Ikeda T; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Tekeuchi T; Mashiba H
    Diabete Metab; 1991; 17(3):373-8. PubMed ID: 1884882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes.
    Kuusi T; Yki-Järvinen H; Kauppinen-Mäkelin R; Jauhiainen M; Ehnholm C; Kauppila M; Seppälä P; Viikari J; Kujansuu E; Rajala S
    Eur J Clin Invest; 1995 Mar; 25(3):194-200. PubMed ID: 7781667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
    Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
    Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
    Alagözlü H; Gültekin F; Candan F
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipoprotein(a) values and severity of coronary artery disease in a large population of patients undergoing coronary angiography.
    Labeur C; De Bacquer D; De Backer G; Vincke J; Muyldermans L; Vandekerckhove Y; Van der Stichele E; Rosseneu M
    Clin Chem; 1992 Nov; 38(11):2261-6. PubMed ID: 1424121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors.
    Kirkman MS; Weinberger M; Landsman PB; Samsa GP; Shortliffe EA; Simel DL; Feussner JR
    Diabetes Care; 1994 Aug; 17(8):840-6. PubMed ID: 7956628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
    Winocour PH; Durrington PN; Bhatnagar D; Mbewu AD; Ishola M; Mackness M; Arrol S
    Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.
    Hiraga T; Kobayashi T; Okubo M; Nakanishi K; Sugimoto T; Ohashi Y; Murase T
    Diabetes Care; 1995 Feb; 18(2):241-4. PubMed ID: 7729305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease.
    Yokoyama I; Yonekura K; Ohtake T; Yang W; Shin WS; Yamada N; Ohtomo K; Nagai R
    J Nucl Med; 2000 Jun; 41(6):978-85. PubMed ID: 10855621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
    Dahlen GH; Guyton JR; Attar M; Farmer JA; Kautz JA; Gotto AM
    Circulation; 1986 Oct; 74(4):758-65. PubMed ID: 2944670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein (a) and vascular disease in diabetic patients.
    James RW; Boemi M; Sirolla C; Amadio L; Fumelli P; Pometta D
    Diabetologia; 1995 Jun; 38(6):711-4. PubMed ID: 7672494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM.
    Velho G; Erlich D; Turpin E; Néel D; Cohen D; Froguel P; Passa P
    Diabetes Care; 1993 May; 16(5):742-7. PubMed ID: 8495614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria.
    Kodama T; Tomiyama T; Ishizaki T; Baba T
    J Diabetes Complications; 1992; 6(2):70-6. PubMed ID: 1611142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.